Oppenheimer Maintains Outperform on Addus HomeCare, Raises Price Target to $130
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Michael Wiederhorn maintains an Outperform rating on Addus HomeCare (NASDAQ:ADUS) and raises the price target from $118 to $130.
June 07, 2024 | 12:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer's analyst Michael Wiederhorn has maintained an Outperform rating on Addus HomeCare and increased the price target from $118 to $130, indicating a positive outlook for the stock.
The increase in the price target from $118 to $130 by a reputable analyst suggests a positive outlook for Addus HomeCare. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100